Protection against Radiation-Induced Carcinogenesis
Protection against Radiation-Induced Carcinogenesis
批准号:
9153721
负责人:
James Mitchell
金额:
$65.79万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AcuteAge-MonthsAnimal FeedAnimalsAutopsyAwarenessBiological MarkersBody WeightCaloric RestrictionCause of DeathChemopreventive AgentChronicControl AnimalDataDevelopmentDietDoseEvaluationExternal Beam Radiation TherapyFaceFemaleFoodFundingGenomic InstabilityGovernment AgenciesHematopoietic NeoplasmsHumanInbred C3H MiceInbred CBA MiceIncidenceIntensity-Modulated RadiotherapyLongevityLymphomaMalignant NeoplasmsMediatingMonitorMouse StrainsMusNeoplasmsNormal tissue morphologyNuclearNuclear AccidentsPatientsPopulationProcessRadiationRadiation InjuriesRadiation OncologyRadiation therapyRadiation-Induced CancerRadiation-Protective AgentsRadioprotectionReagentRiskSecond Primary NeoplasmsSolid NeoplasmSupplementationSurvivorsTestingTimeTissuesToxic effectTumor PathologyUrineWeightWhole-Body Irradiationagedcancer riskcarcinogenesiscytokinedosimetryeffective interventionfallshumane endpointintereststemtempoltumortumorigenesis
中文摘要
我们之前的研究(为期4年)使用雌性C3H和CBA小鼠,在动物食物中添加或不添加Tempol (TP)的情况下,暴露于3gy的全身辐射剂量。在辐射暴露后,动物们立即被放置在对照或含有tp的食物上。各组分为:a)无辐射,对照食品;b) 3 Gy,对照食品;c)无辐射,TP食品;d) 3 Gy, TP食品。对动物(1200只小鼠)进行终身监测,在肿瘤发生或达到人道终点时对小鼠实施安乐死、尸检,并对肿瘤的存在和死亡原因进行病理评估。研究发现,在小鼠饮食中长期补充TP可以减轻体重,但没有毒性,减少癌症,并在非致死性全身辐射(TBI)后延长生存期。Tempol降低了两种小鼠品系中造血肿瘤(淋巴瘤)的发生率;而CBA小鼠非造血肿瘤的发病和发病率均降低。为了更好地了解与这些发现相关的机制,我们进行了为期一年的研究,收集组织以评估基因组不稳定性组织和细胞因子诱导,这些组织目前正在研究中。在过去的一年里,我们还专注于研究,以确定在观察肿瘤肿块之前,接受全身辐射的小鼠尿液中的代谢物是否可以预测辐射诱导的癌症诱导。我们分析了100只小鼠在两年时间内获得的106种尿液代谢物(对照n = 25 0 Gy; n = 75 5.4 Gy)。所分析的每只小鼠的肿瘤病理数据是可用的。使用超过7000种代谢物的主成分分析(PCA)表明,早在tbi后3个月,对照动物的代谢物谱就可以与辐射暴露动物的代谢物谱清晰分离,从而预测肿瘤诱导。此外,受辐射小鼠尿液代谢物的改变也可以区分造血肿瘤和实体肿瘤。最后,TBI治疗小鼠在6月龄时的尿液代谢物谱更类似于老年对照小鼠(18月龄)的尿液代谢物谱。这项研究将在秋季开始重复。总的来说,迄今为止的结果鼓励进一步评估Tempol作为一种化学预防药物,以减少放射治疗一个疗程后放射诱导的第二次恶性肿瘤的发生率。Tempol还可用于降低因核事故或恐怖袭击而暴露于非致命辐射的人群患癌症的风险。辐射后尿液代谢物谱的变化可能为预测辐射诱导的癌症诱导提供一种手段。
英文摘要
Our previous study (conducted over a 4-year period) used both female C3H and CBA mice that were exposed to total body dose of radiation of 3 Gy with or without Tempol (TP) supplementation in the animal's food. Immediately following the radiation exposure, animals were be placed on either control or TP-containing food. The groups included: a) no radiation, control food, b) 3 Gy, control food, c) no radiation, TP food, and d) 3 Gy, TP food. Animals (1200 mice) were monitored for their entire lifespan and upon development of a tumor or when a humane endpoint was reached mice were euthanized, necropsied, and evaluated pathologically for the presence of tumor and cause of death. Chronic supplementation of TP in the diet of mice was found to reduce body weight without toxicity, decreased cancer, and extended survival when administered after non-lethal total body radiation (TBI). Tempol reduced the incidence of hematopoietic neoplasms (lymphomas) in both mouse strains; whereas, both the onset and incidence of non-hematopoietic neoplasms were reduced in CBA mice. To better understand mechanisms associated with these findings we have conducted year-long studies collecting tissue for assessment of genomic instability tissues and cytokine induction and these tissues are currently under study. We have also focused the past year on studies to determine if metabolites in the urine of mice receiving whole body radiation can predict for radiation-induced cancer induction prior to the observation of tumor mass. We have analyzed 106 urine metabolites acquired from 100 mice over a two year period (n = 25 0 Gy control; n = 75 5.4 Gy). Tumor pathology data for each mouse analyzed is available. Principle component analysis (PCA) using over 7000 metabolites indicates that the metabolite profile of control animals can be clearly separated from radiation exposed animals as early as 3 months post-TBI that predict for tumor induction. Further, the alteration in urine metabolites in irradiated mice can also distinguish between hematopoietic and solid tumors. Lastly, the urine metabolite profile of TBI treated mice at 6 months of age more resemble the profile of aged control mice (18 months of age). This study will be replicated beginning in the fall. Collectively, the results to date encourage further evaluation of Tempol as a chemopreventive, to reduce the incidence of radiation-induced second malignancies after a course of definitive radiation therapy. Tempol may also find applications to reduce the risk of cancers in populations exposed to non-lethal radiation due to nuclear accidents or terrorist attacks. Changes in urine metabolite profiles following radiation may provide a means to predict for radiation-induced cancer induction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nitroxides as Protectors Against Oxidative Stress
-
批准号:10487178
-
项目类别:
-
资助金额:$23.68万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Modulation of Therapeutic Response
-
批准号:8554011
-
项目类别:
-
资助金额:$66.27万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Modulation of Therapeutic Response
-
批准号:9154244
-
项目类别:
-
资助金额:$67.78万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Protection against Radiation-Induced Carcinogenesis
-
批准号:8349242
-
项目类别:
-
资助金额:$32.13万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Redox Imaging using Nitroxides and MRI
-
批准号:8349161
-
项目类别:
-
资助金额:$55.7万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Modulation of Therapeutic Response
-
批准号:8350044
-
项目类别:
-
资助金额:$70.69万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Protection against Radiation-Induced Carcinogenesis
-
批准号:10702438
-
项目类别:
-
资助金额:$114.64万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:8938387
-
项目类别:
-
资助金额:$63.42万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Modulation of Therapeutic Response
-
批准号:10262691
-
项目类别:
-
资助金额:$138.88万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:10262693
-
项目类别:
-
资助金额:$27.78万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Modulation of Therapeutic Response
-
批准号:8158259
-
项目类别:
-
资助金额:$64.92万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Protection against Radiation-Induced Carcinogenesis
-
批准号:8937900
-
项目类别:
-
资助金额:$63.42万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:10926566
-
项目类别:
-
资助金额:$58.43万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Modulation of Therapeutic Response
-
批准号:10487176
-
项目类别:
-
资助金额:$118.41万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Imaging Probe Development Center
-
批准号:8746870
-
项目类别:
-
资助金额:$370.3万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Redox Imaging using Nitroxides and MRI
-
批准号:8552827
-
项目类别:
-
资助金额:$30.12万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Redox Imaging using Nitroxides and MRI
-
批准号:7592935
-
项目类别:
-
资助金额:$31.76万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Modulation of Therapeutic Response
-
批准号:10702987
-
项目类别:
-
资助金额:$143.3万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Modulation of Therapeutic Response
-
批准号:10926564
-
项目类别:
-
资助金额:$175.3万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:8763677
-
项目类别:
-
资助金额:$54.34万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位: